Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: GST039
MIFTS: 37

Gastroduodenitis

Categories: Gastrointestinal diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Gastroduodenitis

About this section

MalaCards integrated aliases for Gastroduodenitis:

Name: Gastroduodenitis 12 15 71

Classifications:

MalaCards categories:
Anatomical: Gastrointestinal diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:8644
ICD9CM 34 535.4
SNOMED-CT 67 196737009
ICD10 32 K29.9
UMLS 71 C0029800 C0267166
Sources

Summaries for Gastroduodenitis

About this section
MalaCards based summary : Gastroduodenitis is related to peptic ulcer disease and dieulafoy lesion, and has symptoms including dyspepsia An important gene associated with Gastroduodenitis is ATP12A (ATPase H+/K+ Transporting Non-Gastric Alpha2 Subunit), and among its related pathways/superpathways are Primary immunodeficiency and Secretion of Hydrochloric Acid in Parietal Cells. The drugs Aceclofenac and Naproxen have been mentioned in the context of this disorder. Affiliated tissues include liver, bone marrow and bone.

Sources

Related Diseases for Gastroduodenitis

About this section

Diseases related to Gastroduodenitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 332)
# Related Disease Score Top Affiliating Genes
1 peptic ulcer disease 31.2 GAST ATP4A ATP12A
2 dieulafoy lesion 30.4 ATP4A ATP12A
3 duodenitis 30.1 GAST CD8A CD4 ATP4A ATP12A
4 esophageal varix 30.1 ATP4A ATP12A
5 hernia, hiatus 29.9 GAST ATP4A ATP12A
6 duodenogastric reflux 29.9 GAST ATP4A ATP12A
7 cryptosporidiosis 29.7 CD8A CD4
8 gastritis 10.6
9 duodenal ulcer 10.5
10 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.4
11 vagus nerve disease 10.3 ATP4A ATP12A
12 necrotizing gastritis 10.3 ATP4A ATP12A
13 scalp dermatosis 10.3 ATP4A ATP12A
14 hemangioma of intra-abdominal structure 10.3 ATP4A ATP12A
15 acquired gastric outlet stenosis 10.3 ATP4A ATP12A
16 lingual goiter 10.3 ATP4A ATP12A
17 cascade stomach 10.3 ATP4A ATP12A
18 benzylpenicillin allergy 10.3 ATP4A ATP12A
19 median arcuate ligament syndrome 10.3 ATP4A ATP12A
20 afferent loop syndrome 10.3 ATP4A ATP12A
21 cervix erosion 10.3 ATP4A ATP12A
22 angiodysplasia of intestine 10.3 ATP4A ATP12A
23 angiodysplasia 10.3 ATP4A ATP12A
24 laryngeal tuberculosis 10.3 ATP4A ATP12A
25 fungal esophagitis 10.3 ATP4A ATP12A
26 esophagus melanoma 10.3 ATP4A ATP12A
27 cefuroxime allergy 10.3 ATP4A ATP12A
28 emphysematous cholecystitis 10.3 ATP4A ATP12A
29 superior mesenteric artery syndrome 10.3 ATP4A ATP12A
30 pneumatosis cystoides intestinalis 10.3 ATP4A ATP12A
31 chronic laryngitis 10.3 ATP4A ATP12A
32 laryngitis 10.3 ATP4A ATP12A
33 peptic ulcer perforation 10.3 ATP4A ATP12A
34 viral laryngitis 10.3 ATP4A ATP12A
35 gastroduodenal crohn's disease 10.3 ATP4A ATP12A
36 polyposis, skin pigmentation, alopecia, and fingernail changes 10.3 ATP4A ATP12A
37 central nervous system origin vertigo 10.3 ATP4A ATP12A
38 rumination disorder 10.3 ATP4A ATP12A
39 internal hemorrhoid 10.3 ATP4A ATP12A
40 hemorrhoid 10.3 ATP4A ATP12A
41 acute laryngitis 10.3 ATP4A ATP12A
42 chronic intestinal vascular insufficiency 10.3 ATP4A ATP12A
43 barbiturate abuse 10.3 ATP4A ATP12A
44 gastric dilatation 10.3 ATP4A ATP12A
45 gastric hemangioma 10.3 ATP4A ATP12A
46 blind loop syndrome 10.3 ATP4A ATP12A
47 polycystic echinococcosis 10.3 ATP4A ATP12A
48 diclofenac allergy 10.3 ATP4A ATP12A
49 x-linked chondrodysplasia punctata 1 10.3 ATP4A ATP12A
50 duodenal obstruction 10.3 ATP4A ATP12A

Comorbidity relations with Gastroduodenitis via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Gastroduodenitis:



Diseases related to Gastroduodenitis
Sources

Symptoms & Phenotypes for Gastroduodenitis

About this section

UMLS symptoms related to Gastroduodenitis:


dyspepsia
Sources

Drugs & Therapeutics for Gastroduodenitis

About this section

Drugs for Gastroduodenitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 85)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aceclofenac Approved, Investigational Phase 4 89796-99-6 71771
2
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
3
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
4
Clopidogrel Approved Phase 4 120202-66-6, 113665-84-2 60606
5
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
6
Famotidine Approved Phase 4 76824-35-6 3325
7
Acetaminophen Approved Phase 4 103-90-2 1983
8
Rabeprazole Approved, Investigational Phase 4 117976-89-3 5029
9
Histamine Approved, Investigational Phase 4 51-45-6, 75614-87-8 774
10
Loxoprofen Approved Phase 4 68767-14-6, 80382-23-6 3965
11
Misoprostol Approved Phase 4 59122-46-2 5282381
12
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
13
Dexlansoprazole Approved, Investigational Phase 4 138530-94-6, 103577-45-3 9578005
14
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
15 Anti-Inflammatory Agents Phase 4
16 Analgesics, Non-Narcotic Phase 4
17 Anti-Inflammatory Agents, Non-Steroidal Phase 4
18 Analgesics Phase 4
19 Antirheumatic Agents Phase 4
20 Cyclooxygenase Inhibitors Phase 4
21 Neurotransmitter Agents Phase 4
22 Cyclooxygenase 2 Inhibitors Phase 4
23 Platelet Aggregation Inhibitors Phase 4
24 Fibrinolytic Agents Phase 4
25 Purinergic P2Y Receptor Antagonists Phase 4
26 Antipyretics Phase 4
27
Histamine Phosphate Phase 4 51-74-1 65513
28 Histamine Antagonists Phase 4
29 Histamine H2 Antagonists Phase 4
30 Pharmaceutical Solutions Phase 4
31 Ranitidine bismuth citrate Phase 4
32
Cisplatin Approved Phase 2, Phase 3 15663-27-1 84093 441203 2767
33
Doxorubicin Approved, Investigational Phase 2, Phase 3 23214-92-8 31703
34
Triamcinolone Approved, Vet_approved Phase 2, Phase 3 124-94-7 31307
35
Capecitabine Approved, Investigational Phase 2, Phase 3 154361-50-9 60953
36
Hydrocortisone acetate Approved, Vet_approved Phase 2, Phase 3 50-03-3
37
Hydrocortisone Approved, Vet_approved Phase 2, Phase 3 50-23-7 5754
38
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239 406563
39
Esomeprazole Approved, Investigational Phase 3 161796-78-7, 161973-10-0, 119141-88-7 9568614 4594
40
Ketoprofen Approved, Vet_approved Phase 3 22071-15-4 3825
41
Fluorouracil Approved Phase 3 51-21-8 3385
42
leucovorin Approved Phase 3 58-05-9 6006
43
Oxaliplatin Approved, Investigational Phase 3 61825-94-3 5310940 9887054 6857599 43805
44
Ethanol Approved Phase 3 64-17-5 702
45 Ethiodized oil Approved, Investigational Phase 3 8008-53-5
46 Hypnotics and Sedatives Phase 2, Phase 3
47 Triamcinolone hexacetonide Phase 2, Phase 3
48 triamcinolone acetonide Phase 2, Phase 3
49 Triamcinolone diacetate Phase 2, Phase 3
50 Hydrocortisone hemisuccinate Phase 2, Phase 3

Interventional clinical trials:

(show all 49)
# Name Status NCT ID Phase Drugs
1 Protective Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Unknown status NCT02175186 Phase 4 ALBIS;Placebo
2 A Phase IV Clinical Trial to Evaluate the Preventive Effectiveness of NSAID-Associated Gastroduodenal Injury (Multi-center, Double-blind, Active-controlled, Stratified Randomized, Parallel Group) Completed NCT01912066 Phase 4 Stillen;Cytotec (reference drug);NSAID (Aceclofenac)
3 A Randomized, Blinded, Placebo-Controlled Study of the Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on Gastroduodenal Healing Completed NCT00778193 Phase 4 Naproxen;Aspirin;Celecoxib;Clopidogrel;Placebo
4 A Multicenter, Randomized, Active-Controlled Comparison Study of the Incidence of Gastroduodenal Ulcers Associated With Celecoxib and Low Dose ASA Versus Naproxen and Low Dose ASA in Healthy Subjects (50-75 Years of Age) Completed NCT00137033 Phase 4 Celecoxib;Naproxen;ASA
5 Does Acetaminophen Potentiate the Gastroduodenal Mucosal Injury of Aspirin? A Prospective, Randomized, Pilot Study. Completed NCT00594867 Phase 4 Acetaminophen - 4 grams per day + Placebo;Aspirin - 325 mg per day + Placebo;Acetaminophen 4 gram per day + Aspirin 325 mg per day
6 Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-Induced Damage by Rabeprazole Completed NCT00220857 Phase 4 Rabeprazole
7 Prevention of Recurrent Idiopathic Gastroduodenal Ulcer Bleeding: a Double-blind Randomized Trial Completed NCT01180179 Phase 4 Lansoprazole;Famotidine
8 A Randomized, Placebo-Controlled, Double-Blind, Phase 4 Study To Compare The Effect Of Celecoxib 100 Mg BID, Loxoprofen 60 Mg TID And Placebo On The Gastroduodenal Mucosa In Healthy Subjects Completed NCT00994461 Phase 4 Celecoxib;Loxoprofen;Placebo
9 The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD) - a Randomized-controlled Trial - Recruiting NCT04465032 Phase 4
10 Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer: a Double-blind Randomised Trial on Misoprostol Combined With Lansoprazole Versus Lansoprazole Alone (NRT_MISO Study) Recruiting NCT03675672 Phase 4 Misoprostol Oral Tablet;Placebo Oral Tablet
11 A Prospective, Randomized, Double-Blind Protocol to Compare the Efficacy of Lansoprazole to Ranitidine in Healing Pre-Existing and/or Preventing the Development of Gastroduodenal Stress Ulceration and Postoperative Bleeding in Patients Undergoing Elective Coronary Artery Bypass Graft or Cardiac Valve Replacement Surgery Terminated NCT00220909 Phase 4 Lansoprazole
12 Low Dose Against High Dose of Proton Pump Inhibitors in Treatment Acute Peptic Ulcer Bleeding Withdrawn NCT02724150 Phase 4 Omeprazole High dose;Omeprazole Low dose
13 Randomized Control Trial of Transarterial Chemotherapy (TAC) Versus Oral Thalidomide and Capecitabine in the Treatment of Unresectable Hepatocellular Carcinoma Unknown status NCT02240771 Phase 2, Phase 3 Oral chemotherapy
14 Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma Unknown status NCT00522405 Phase 2, Phase 3
15 Study of Gastroduodenal Metallic Stent vs Gastrojejunostomy Unknown status NCT02784470 Phase 3
16 A Phase III Randomized Trial of Comparison of Survival Benefit of Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin With Sorafenib for Patients With Barcelona-Clinic Liver Cancer (BCLC)-C Stage Hepatocellular Carcinoma Completed NCT03164382 Phase 3 FOLFOX regimen;Sorafenib 200Mg Tab
17 A Double-blind Randomized Placebo Controlled Trial of Rabeprazole for Prevention of NSAID-associated Dyspepsia and Gastroduodenal Injury Completed NCT01140828 Phase 3 Rabeprazole;Rabeprazole Placebo
18 A Randomized Double-Blind Placebo-Controlled Study to Assess the Prevention of Low-Dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 mg Once Daily for 26 Weeks. Completed NCT00251966 Phase 3 Esomeprazole
19 Safety, Tolerability and Efficacy of FDC Ketoprofen + Omeprazole in Patients With Rheumatological Conditions With History or Who Are at Risk of Developing NSAID Associated Benign Gastric Ulcers, Duodenal Ulcers and Gastroduodenal Erosions Completed NCT00971581 Phase 3 FDC KETOPROFEN+OMEPRAZOLE
20 The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Compared With Transarterial Chemoembolization as Initial Treatment in Patients With Large Hepatocellular Carcinoma Staged BCLC A/B. Active, not recruiting NCT02973685 Phase 3 Folfox Protocol;TACE Drug Protocol
21 Phase II Multicenter Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Toxicity and Outcome Completed NCT01850667 Phase 2
22 A Multi-center, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone for the Prevention of NSAID-induced Gastroduodenal Injury in Patients With Osteoarthritis and/or Rheumatoid Arthritis Patients Completed NCT00597818 Phase 2 Cobiprostone;Placebo;Non-steroidal anti-inflammatory drug
23 A Phase 2 Clinical Trial Evaluating the Incidence of Upper Gastrointestinal Mucosal Damage Following Administration of Either PL3100 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated GI Damage Completed NCT01139190 Phase 2 PL3100;Naproxen
24 A Randomized, Blinded, Endoscopic Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects Completed NCT01646814 Phase 2 PL2200;Aspirin tablets
25 Evaluation of Sorafenib in Combination With Local Micro-therapy Guided by Gd-EOB-DTPA Enhanced MRI in Patients With Inoperable Hepatocellular Carcinoma Completed NCT01126645 Phase 2
26 Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus Completed NCT00644241 Phase 2
27 The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Compared With Transarterial Chemoembolization in Patients With Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B Completed NCT03048123 Phase 2 Folfox Protocol;TACE Drug Protocol
28 A Two-Part, Randomised, Open-Label, Evaluator-Blinded, Multiple-Dose, Phase I Pilot Study With OXP001 Ibuprofen 400 mg Tablets and Brufen® 400 mg Tablets to Assess the Comparative Bioavailability (Part 1) and Effects on Gastroduodenal Irritation (Part 2) in Healthy Human Subjects Completed NCT02521207 Phase 1 Ibuprofen
29 Pilot Study of OXP005 to Assess Gastroduodenal Irritation Completed NCT02408978 Phase 1 OXP005;Naproxen
30 A Multicenter, Randomized, Placebo And Active-Controlled Study Of The Effect Of CJ-023,423 On The Incidence Gastroduodenal Endoscopic Ulcers In Healthy Subjects Completed NCT00392080 Phase 1 CJ-023,423;placebo;naproxen
31 Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib Completed NCT00700687 Phase 1 PA32540;PA32540 and celecoxib;aspirin and [NSAID]
32 SCANDIUM II Trial - A Phase I Randomized Controlled Multicentre Trial of Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases Not yet recruiting NCT04463368 Phase 1 Ipilimumab;Nivolumab
33 Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer: Multicenter Prospective Randomized Comparison Study Unknown status NCT01742806
34 Endoscopic Treatment of Recurrent Upper GI Bleeding From Gastroduodenal Ulcers: OTSC [Over the Scope Clip] Versus Standard Therapy Unknown status NCT01836900
35 Changes in Pancreatic Texture After Single-shot Administration of 500 µg Octreotide in the Gastroduodenal Artery During Pancreatoduodenectomy - a Double-Blinded Randomized Controlled Trial Completed NCT01400100 Intraarterial application of Octreotide;sterile NaCl (sodium chloride) 0,9% solution
36 Efficacy of Low Dose of Proton Pumb Inhabitor in Treatment Upper Gastrointestinal Bleeding Completed NCT03163680 Omeprazole 40 MG
37 The Effect of Newly Designed Covered Self-expandable Metallic Stents Insertion Using Clips and Suture Materials for Preventing Migration in Benign Stricture of Gastroduodenal Anastomosis: a Pilot Study Completed NCT02193789
38 Changes in Lipid Indices and Body Composition One Year After Laparoscopic Gastrectomy: a Prospective Study Completed NCT02541461
39 Pancreatoduodenectomy With or Without Prophylactic Ligamentum Teres Hepatic Wrap Around the Gastroduodenal Artery Stump for Prevention of Pancreatic Hemorrhage - Panda - Multicentric Randomized Controlled Trial Completed NCT02588066
40 The Influence of Biopsy Number and Site on the Sensitivity of Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Bleeding Gastroduodenal Ulcer Completed NCT01282853
41 New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers Completed NCT04239118
42 Endoscopic Injection of Autologous Blood Versus Diluted Epinephrine for Control of Actively Bleeding Gastroduodenal Ulcers Completed NCT01560702 Epinephrine
43 Diagnosis of Gastroduodenal Diseases by Proteiomic Fingerprints of Gastric Juice Completed NCT00834236
44 Combined Infusion System to Deliver Chemotherapy Regionally to the Liver Recruiting NCT04684862
45 Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer Recruiting NCT04136769
46 To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology (CGDP) in Schoolchildren in the Primary Health Care System. Active, not recruiting NCT04702542 Enteral oxygen therapy
47 Comparison Between Laparoscopic and Open Repair of Perforated Gastroduodenal Peptic Ulcer Enrolling by invitation NCT04447170
48 An Open-Label, Randomized, Two-sequence, Two-period, Fasting Condition, Single Oral Dose, Cross-over Study of Bioequivalence of "Gaster®D Tab20mg (Famotidine) (Changed Manufacturer)" and "Gaster®D Tab 20mg (Famotidine) (Unchanged Manufacturer, Announced Reference Drug)" in Healthy, Adult, Human Subjects Not yet recruiting NCT04123899 IGAD→GSTD;GSTD→IGAD
49 Effect of T6 Dermatome Electrical Stimulation on Gastroduodenal Motility in Healthy Volunteers Terminated NCT03316105

Search NIH Clinical Center for Gastroduodenitis

Sources

Genetic Tests for Gastroduodenitis

About this section
Sources

Anatomical Context for Gastroduodenitis

About this section

MalaCards organs/tissues related to Gastroduodenitis:

40
Liver, Bone Marrow, Bone, Pancreas, T Cells, Small Intestine, Kidney
Sources

Publications for Gastroduodenitis

About this section

Articles related to Gastroduodenitis:

(show top 50) (show all 555)
# Title Authors PMID Year
1
Gastroduodenitis associated with ulcerative colitis: A case report. 61
32953863 2020
2
Esophageal Ulcers Associated with Ulcerative Colitis: A Case Series and Literature Review. 61
32448835 2020
3
Severe cytomegalovirus gastritis after pembrolizumab in a patient with melanoma. 61
32905211 2020
4
Prevalence and Clinical Manifestations of Helicobacter Pylori with Reference to Histopathological Diagnosis. 61
33582691 2020
5
Phenotype and Molecular Detection of Clarithromycin and Levofloxacin Resistance in Helicobacter pylori Clinical Isolates in Beijing. 61
32753910 2020
6
Endoscopic Findings in Persistent Dyspepsia in Secondary Care Hospital Setting in North Kashmir. 61
31561689 2019
7
Evaluation of upper gastrointestinal system in acromegaly. 61
31227172 2019
8
Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanoma. 61
31304833 2019
9
Antibiotic Resistance and Genotypes of Helicobacter pylori Strains in Patients with Gastroduodenal Disease in Southeast Poland. 61
31330898 2019
10
Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. 61
30825968 2019
11
MALT Lymphoma as a Model of Chronic Inflammation-Induced Gastric Tumor Development. 61
31123886 2019
12
[Survey assesment of vitamin D and calcium dietary intake in children with somatic pathology]. 61
31710788 2019
13
Assessment of the effectiveness of the gastropathy risk reduction program in patients with arterial hypertension. 61
31050990 2019
14
MORPHOLOGICAL CHARACTERISTICS OF CHRONIC GASTRODUODENITIS IN ADOLESCENTS WITH FOOD HYPERSENSITIVITY. 61
30618397 2018
15
CagA and vacA allelic combination of Helicobacter pylori in gastroduodenal disorders. 61
29908307 2018
16
[Comorbidities and concomitant medication use in adult patients with chronic hepatitis C: a descriptive epidemiological analysis]. 61
29804396 2018
17
Comorbid for gastroduodenal ulcers in the aspect of calcium imbalance and blockers of slow calcium channels in their treatment. 61
30701769 2018
18
Acute Gastrointestinal Bleeding in Olmesartan-Associated Collagenous Gastroduodenitis: A Potential Endoscopic Complication. 61
29732226 2018
19
Late Relapse of Henoch-Schönlein Purpura in an Adolescent Presenting as Severe Gastroduodenitis. 61
30525016 2018
20
Strongyloidosis Hyperinfection Syndrome in an HIV-Infected Patient: A Rare Manifestation of Immune Reconstitution Inflammatory Syndrome. 61
30510823 2018
21
Non-perforated peptic ulcer disease: multidetector CT findings, complications, and differential diagnosis. 61
28677101 2017
22
Correlation between Endoscopic and Histopathological Findings in Dogs with Chronic Gastritis. 61
29978094 2017
23
Fungal Gastroduodenitis. 61
30755955 2017
24
Adult Behcet's disease in Iran: analysis of 6075 patients. 61
26258691 2016
25
Serum Cytokine Signature That Discriminates Helicobacter pylori Positive and Negative Juvenile Gastroduodenitis. 61
28018296 2016
26
Collagenous gastroduodenitis with recurrent gastric ulcer in 12-year-old girl. 61
26011716 2015
27
Near fatal 5-FU gut toxicity post surgery--remarkable effect of high-dose sucralfate. 61
24571246 2015
28
[DISSEMINATION BY H. PYLORI IN PATIENTS, SUFFERING VARIOUS FORMS OF CHOLECYSTITIS]. 61
26419024 2015
29
[DYNAMICS OF APOPTOTIC MARKERS (INTERLEUKIN-2 AND TNF-α) IN THE BLOOD SERUM OF CHILDREN WITH CHRONIC GASTRODUODENITES]. 61
26281156 2015
30
PECULIARITIES OF THE COURSE OF THE UPPER ALIMENTARY TRACT DISEASES IN CHILDREN WITH BRONCHOOBSTRUCTIVE SYNDROME. 61
26817101 2015
31
[PEDIATRIC GASTROENTEROLOGY: ORIGINS, PROBLEMS, AND PROSPECTS OF THE RESEARCH]. 61
26281153 2015
32
[THE CORRECTION OF TROPHIC DISORDERS IN CHILDREN OF CHRONIC GASTRODUODENITIS WITH METHOD LOW-FREQUENCY LIGHT-MAGNETOTHERAPY]. 61
26281157 2015
33
Systemic classification for a new diagnostic approach to acute abdominal pain in children. 61
25587522 2014
34
Prevalence of asymptomatic gastroduodenal lesions and Helicobacter pylori infection in kidney transplant candidates. 61
25509697 2014
35
Collagenous gastroduodenitis coexisting repeated Dieulafoy ulcer: A case report and review of collagenous gastritis and gastroduodenitis without colonic involvement. 61
26184019 2014
36
Peculiarities of gastrointestinal disease concomitant to heart connective tissue dysplasia in children born from persons exposed to ionizing radiation in childhood after the ChNPP accident. 61
25536566 2014
37
Results of drug correction of structural and functional changes in the gingiva in experimental gastroduodenitis. 61
24824716 2014
38
Unidentified intralesional and intracellular coccoid microorganism discovered in the young man with a diffuse erosive gastroduodenitis and multiple superficial ulcerations. 61
24495976 2014
39
Clinical features and treatment of ulcerative colitis-related severe gastroduodenitis and enteritis with massive bleeding after colectomy. 61
24105365 2014
40
Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type. 61
24333758 2014
41
[Holter monitoring data in children with gastroesophageal reflux disease]. 61
25518451 2014
42
[Biliary dysfunction in obese children]. 61
25911906 2014
43
[Mucosal immune response to Helicobacter pylori in children with gastroduodenal diseases and allergy]. 61
25916130 2014
44
[Features of mucosal lesions of stomach and duodenum in children with chronic gastroduodenitis with different microflora content]. 61
25816643 2014
45
[The clinical significance of evaluation of the inflammatory infiltrate in chronic gastroduodenitis in children]. 61
25518455 2014
46
[Clinical and immunological assessment of Polyoxidonium and Tantum Verde efficiency by catarrhal gingivitis treatment in children with chronic gastroduodenitis]. 61
24576969 2014
47
[Causes of chronic gastrodudenal and bone disorder development in children living under the effect of human induced ecological factors (literature review)]. 61
25518463 2014
48
[Cycloferon therapy of chronic gastroduodenitis in children]. 61
25975104 2014
49
Diffuse gastroduodenitis associated with ulcerative colitis: treatment by infliximab. 61
24164601 2013
50
Detection and genotyping of Helicobacter pylori gene vacA in children with gastroduodenal diseases and in adults with gastric cancer in Vladivostok. 61
23667879 2013
Sources

Variations for Gastroduodenitis

About this section
Sources

Expression for Gastroduodenitis

About this section
Search GEO for disease gene expression data for Gastroduodenitis.
Sources

Pathways for Gastroduodenitis

About this section

Pathways related to Gastroduodenitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Primary immunodeficiency 36
10.54 CD8A CD4
2
Secretion of Hydrochloric Acid in Parietal Cells 1
9.32 GAST ATP4A
Sources

GO Terms for Gastroduodenitis

About this section

Biological processes related to Gastroduodenitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.56 CXCL6 CD8A CD4 CCL26
2 cellular sodium ion homeostasis GO:0006883 9.32 ATP4A ATP12A
3 sodium ion export across plasma membrane GO:0036376 9.16 ATP4A ATP12A
4 cellular potassium ion homeostasis GO:0030007 8.96 ATP4A ATP12A
5 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 8.62 ATP4A ATP12A

Molecular functions related to Gastroduodenitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP4A ATP12A
2 potassium-transporting ATPase activity GO:0008556 8.96 ATP4A ATP12A
3 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A
Sources

Sources for Gastroduodenitis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....